Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Rockwell Automation
ROK
$49.8B
| $41.5M | 0.03% |
145,038
+8,209
| +6% | +$2.21M |
|
|
PACW
227
DELISTED
PacWest Bancorp
PACW
| $41.4M | 0.03% |
1,005,372
-42,669
| -4% | -$1.83M |
|
228
Webster Financial
WBS
$12.7B
| $41.4M | 0.03% |
775,770
-32,783
| -4% | -$1.82M |
|
229
New Oriental
EDU
$8.9B
| $40.3M | 0.03% |
491,647
-627
| -0.1% | -$76.1K |
|
230
iShares Core US Aggregate Bond ETF
AGG
$138B
| $39.1M | 0.02% |
339,441
+36,088
| +12% | +$4.13M |
|
231
Dine Brands
DIN
$449M
| $39M | 0.02% |
436,636
-13,017
| -3% | -$1.2M |
|
232
Vericel Corp
VCEL
$2.35B
| $38.4M | 0.02% |
731,092
+444,216
| +155% | +$25.3M |
|
233
TAL Education Group
TAL
$6.55B
| $37.7M | 0.02% |
1,493,125
-33,974
| -2% | -$1.52M |
|
234
Prestige Consumer Healthcare
PBH
$2.46B
| $36.9M | 0.02% |
708,532
-70,592
| -9% | -$3.39M |
|
235
Omnicell
OMCL
$1.68B
| $36.9M | 0.02% |
243,482
+4,901
| +2% | +$682K |
|
|
DENN
236
DELISTED
Denny's
DENN
| $36.7M | 0.02% |
2,226,838
-63,538
| -3% | -$1.11M |
|
237
Biogen
BIIB
$30.3B
| $36.4M | 0.02% |
105,075
+6,497
| +7% | +$1.97M |
|
238
Helmerich & Payne
HP
$3.43B
| $35.9M | 0.02% |
1,099,617
+965
| +0.1% | +$28.4K |
|
239
Freshpet
FRPT
$3.02B
| $35.5M | 0.02% |
217,581
+6,603
| +3% | +$1.13M |
|
240
Alcon
ALC
$34.5B
| $35.2M | 0.02% |
501,235
-34,458
| -6% | -$2.45M |
|
241
Oceaneering
OII
$4.97B
| $34.8M | 0.02% |
2,232,820
-37,418
| -2% | -$522K |
|
242
Honeywell
HON
$78.5B
| $33.8M | 0.02% |
163,284
+5,996
| +4% | +$1.27M |
|
243
ON Semiconductor
ON
$31.3B
| $33.2M | 0.02% |
868,120
+24,957
| +3% | +$980K |
|
244
RLJ Lodging Trust
RLJ
$1.88B
| $32.6M | 0.02% |
2,142,904
-70,954
| -3% | -$1.11M |
|
245
Delek US
DK
$4.02B
| $32.5M | 0.02% |
1,501,319
-1,810
| -0.1% | -$40.9K |
|
246
Rogers Corp
ROG
$2.35B
| $31.9M | 0.02% |
158,787
-386
| -0.2% | -$73.7K |
|
247
IPG Photonics
IPGP
$3.88B
| $31.8M | 0.02% |
150,949
-856
| -0.6% | -$180K |
|
248
BioCryst Pharmaceuticals
BCRX
$2.28B
| $31.8M | 0.02% |
+2,011,231
| New | +$27.3M |
|
249
Emergent Biosolutions
EBS
$392M
| $31.2M | 0.02% |
495,417
+13,685
| +3% | +$879K |
|
250
Century Aluminum
CENX
$4.64B
| $30.9M | 0.02% |
2,400,619
-164,551
| -6% | -$2.37M |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.